Literature DB >> 19089674

Vesicourethral dysfunction in multiple sclerosis. Initial assessment based on lower urinary tract symptoms and their pathophysiology.

Paolo Di Benedetto1, Cristina Delneri, Emanuele Biasutti, Luisa Monti Bragadin, Tullio Giorgini.   

Abstract

The most common lower urinary tract symptoms (LUTS) in multiple sclerosis (MS) are irritative, obstructive or mixed (association of irritative and obstructive LUTS). Generally irritative LUTS are typical in patients with cortical, brainstem or mild spinal cord lesions; obstructive symptoms are frequent in patients with spinal cord lesions (below the pontine micturition centre) or at the level of the sacral micturition centre. Irritative LUTS are often associated with detrusor overactivity, whereas obstructive LUTS are associated with detrusor sphincter dyssynergia or detrusor areflexia/hypocontractility. Proper management of these LUTS often could be planned without specialised assessment, in accordance with the algorithms proposed by International Consultation on Incontinence.

Entities:  

Mesh:

Year:  2008        PMID: 19089674     DOI: 10.1007/s10072-008-1041-z

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  14 in total

1.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

Review 2.  Sexual and urological dysfunction in multiple sclerosis: better understanding and improved therapies.

Authors:  Ranan DasGupta; Clare J Fowler
Journal:  Curr Opin Neurol       Date:  2002-06       Impact factor: 5.710

3.  Urodynamic findings in primary progressive multiple sclerosis are associated with increased volumes of plaques and atrophy in the central nervous system.

Authors:  M Ukkonen; I Elovaara; P Dastidar; T L J Tammela
Journal:  Acta Neurol Scand       Date:  2004-02       Impact factor: 3.209

Review 4.  Neurological disorders of micturition and their treatment.

Authors:  C J Fowler
Journal:  Brain       Date:  1999-07       Impact factor: 13.501

5.  A PET study on brain control of micturition in humans.

Authors:  B F Blok; A T Willemsen; G Holstege
Journal:  Brain       Date:  1997-01       Impact factor: 13.501

6.  The correlation of urodynamic findings with cranial magnetic resonance imaging findings in multiple sclerosis.

Authors:  Y H Kim; C Goodman; E Omessi; V Rivera; M W Kattan; T B Boone
Journal:  J Urol       Date:  1998-03       Impact factor: 7.450

7.  Urodynamic pattern changes in multiple sclerosis.

Authors:  S J Ciancio; S E Mutchnik; V M Rivera; T B Boone
Journal:  Urology       Date:  2001-02       Impact factor: 2.649

8.  Urinary tract dysfunction in multiple sclerosis: is there a relation with disease-related parameters?

Authors:  D Porru; G Campus; A Garau; M Sorgia; A C Pau; G Spinici; M P Pischedda; M G Marrosu; R M Scarpa; E Usai
Journal:  Spinal Cord       Date:  1997-01       Impact factor: 2.772

Review 9.  The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines.

Authors:  Marianne de Sèze; Alain Ruffion; Pierre Denys; Pierre-Alain Joseph; Brigitte Perrouin-Verbe
Journal:  Mult Scler       Date:  2007-03-15       Impact factor: 6.312

10.  Neurourologic abnormalities in multiple sclerosis.

Authors:  I Goldstein; M B Siroky; D S Sax; R J Krane
Journal:  J Urol       Date:  1982-09       Impact factor: 7.450

View more
  4 in total

Review 1.  Botulinum neurotoxin-A treatment of lower urinary tract symptoms in multiple sclerosis.

Authors:  Oussama El Yazami Adli; Jacques Corcos
Journal:  Can Urol Assoc J       Date:  2014-01       Impact factor: 1.862

2.  Recommendations for the management of urinary disorders in multiple sclerosis: a consensus of the Italian Multiple Sclerosis Study Group.

Authors:  A Ghezzi; R Carone; G Del Popolo; M P Amato; A Bertolotto; M Comola; U Del Carro; P Di Benedetto; A Giannantoni; M L Lopes de Carvalho; E Montanari; F Patti; A Protti; S Rasia; A Salonia; C Scandellari; F Sperli; M Spinelli; C Solaro; A Uccelli; M Zaffaroni; V Zipoli
Journal:  Neurol Sci       Date:  2011-12       Impact factor: 3.307

Review 3.  Autonomic Dysregulation in Multiple Sclerosis.

Authors:  Alexandra Pintér; Domonkos Cseh; Adrienn Sárközi; Ben M Illigens; Timo Siepmann
Journal:  Int J Mol Sci       Date:  2015-07-24       Impact factor: 5.923

4.  Feasibility and acceptability of transcutaneous tibial nerve stimulation for the treatment of bladder storage symptoms among people with multiple sclerosis.

Authors:  Hawra B Al Dandan; Rose Galvin; Katie Robinson; Doreen McClurg; Susan Coote
Journal:  Pilot Feasibility Stud       Date:  2022-07-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.